| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/29/2002 | WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO2000023569A9 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/29/2002 | WO2000022115A9 Assays for identifying functional alterations in the p53 tumor suppressor |
| 08/29/2002 | WO1999060014A9 Methods and compounds for modulating nuclear receptor coactivator binding |
| 08/29/2002 | WO1999057280A9 Neisseria meningitidis antigens and compositions |
| 08/29/2002 | WO1999045358A8 Identification and expression of human kir5.1 |
| 08/29/2002 | US20020120964 Relates to a glyphosate tolerant cotton plant PV- GHGT07(1445) and to assays for detecting its presence; detection methods of Roundup Ready registered cotton and progeny; DNA from the cotton cell flanking the insertion site and is diagnostic |
| 08/29/2002 | US20020120963 Genes isolated from Arabidopsis coding for proteins essential for seedling growth; using these proteins to discover new herbicides, based on their essentiality for normal growth and development screening assay to identify inhibitors |
| 08/29/2002 | US20020120959 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor |
| 08/29/2002 | US20020120956 Plant breeding programs using gummy stem blight resistant Cucumis melo seeds, plants, breeding lines, pollen, ovules, and tissue culture; crossing a first a second C. melo plant to yield a first non-resistant and a second resistant seed |
| 08/29/2002 | US20020120954 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor |
| 08/29/2002 | US20020120953 Semicontinuous culture of plant cells in a nutrient medium;monitoring the pH of the medium to monitor expression of an expression product encoded by a polynucleotide under the control of an inducible promoter; antitrypsin |
| 08/29/2002 | US20020120951 Transgenic mice containing FPR-RS4 gene disruptions |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120947 Protein-protein interactions in neurodegenerative disorders |
| 08/29/2002 | US20020120405 Protein data analysis |
| 08/29/2002 | US20020120125 Polycomb genes from maize - Mez1 and Mez2 |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120121 Antisense therapy of cancer; Inhibitors of Apoptosis Proteins (IAPs) and an additional related antiapoptotic protein, NAIP; |
| 08/29/2002 | US20020120120 Nucleic acid sequences of genes encoding high mobility group proteins and uses thereof |
| 08/29/2002 | US20020120119 2,5-diketo-D-gluconic acid (2,5-DKG); nucleotides encoding the enzyme; useful in biosynthesis of ascorbic acid |
| 08/29/2002 | US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example |
| 08/29/2002 | US20020120116 Enterococcus faecalis polynucleotides and polypeptides |
| 08/29/2002 | US20020120115 Isolated polynucleotide encoding an outer membrane protein of Ehrlichia canis; immunoassay; vaccines; diagnostic kits |
| 08/29/2002 | US20020120114 Pesticidal toxins and genes from bacillus laterosporus strains |
| 08/29/2002 | US20020120112 Lymphoma associated molecules and uses therefor |
| 08/29/2002 | US20020120111 Dwarf5 (dwf5); dwf5 mutants are defective in a step mediated by an S7R (sterol Delta 7 reductase); polynucleotides; use to extend flowering, produce larger leaves or fruit, increase seed production; transgenic plants |
| 08/29/2002 | US20020120110 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 08/29/2002 | US20020120106 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107, antibodies specific for the peptides and methods of stimulating immune response; antisense agents |
| 08/29/2002 | US20020120104 Myc family of nuclear proto-oncogenes; nucleic acid of given sequence; possible use treating cancer |
| 08/29/2002 | US20020120103 17 human secreted proteins |
| 08/29/2002 | US20020120102 Native Arg-Gly-Asp (RGD) motif has been deleted or has been replaced by an amino acid sequence having no integrin- binding activity, or an integrin-binding amino acid sequence other than RGD which contains aspartic acid or glutamic acid |
| 08/29/2002 | US20020120101 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 08/29/2002 | US20020120096 Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage |
| 08/29/2002 | US20020119943 Novel mammalian gene,bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 08/29/2002 | US20020119942 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/29/2002 | US20020119940 Gene expression and delivery systems and uses |
| 08/29/2002 | US20020119937 Culture product from Streptomyces |
| 08/29/2002 | US20020119931 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 08/29/2002 | US20020119929 Fertility; genetic engineering |
| 08/29/2002 | US20020119927 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119925 Serine proteases |
| 08/29/2002 | US20020119924 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 08/29/2002 | US20020119921 Thrombospondin-2 and uses thereof |
| 08/29/2002 | US20020119920 Genetic engineering; diagnosis, therapy |
| 08/29/2002 | US20020119919 Nucleic acids, proteins, and antibodies |
| 08/29/2002 | US20020119917 Rheumatic disease |
| 08/29/2002 | US20020119915 Dietetics |
| 08/29/2002 | US20020119572 Direct, externally imposed control of polypeptides |
| 08/29/2002 | US20020119565 Isolation and use of solid tumor stem cells |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119553 Human secreted protein, ZZP1 |
| 08/29/2002 | US20020119552 Human oncogene induced secreted protein I |
| 08/29/2002 | US20020119549 Nucleotide sequences which code for the RPSL gene |
| 08/29/2002 | US20020119547 58569 and 50111, human proteins and methods of use thereof |
| 08/29/2002 | US20020119545 Isolated mammalian nucleic acid molecule encoding a receptor protein tyrosine kinase expressed in primitive hematopcietic cells and not expressed in mature hematopoietic cells |
| 08/29/2002 | US20020119541 Tumor suppressor CAR-1 |
| 08/29/2002 | US20020119540 Novel human ion channel protein and polynucleotides encoding the same |
| 08/29/2002 | US20020119539 Isolation of purified tgf -beta1 and tgf -beta2 from bone tissue |
| 08/29/2002 | US20020119537 Which encode the beta-subunit of RNA polymerase B |
| 08/29/2002 | US20020119529 Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
| 08/29/2002 | US20020119528 Nucleotide sequences coding polypeptide for use inthe treatment of leukemia, tumors, infections, autoimmune disease, fibrosis, psoriasis and brain disorders |
| 08/29/2002 | US20020119527 Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 08/29/2002 | US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 08/29/2002 | US20020119525 TAB1 protein and DNA coding therefore |
| 08/29/2002 | US20020119524 Novel molecules of the T129-related protein family and uses thereof |
| 08/29/2002 | US20020119523 Nucleotide sequences coding polypeptides for use in the treatment of cancer, nervous system and blood disorders |
| 08/29/2002 | US20020119522 Novel human ion channel-related proteins and polynucleotides encoding the same |
| 08/29/2002 | US20020119521 Expression vector or use as tools in gene therapy |
| 08/29/2002 | US20020119520 Polypeptide for use in the screening of bactericides and preventing infections |
| 08/29/2002 | US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders |
| 08/29/2002 | US20020119518 Peptide for use in treatment and diagnosis of heart defects |
| 08/29/2002 | US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight |
| 08/29/2002 | US20020119512 Ups |
| 08/29/2002 | US20020119511 Enzymatic polypeptide for use in screening bactericides; for use in prevention of infections |
| 08/29/2002 | US20020119510 Enzymatic polypeptide for use in screening bactericides |
| 08/29/2002 | US20020119509 Essential fungal genes and their use |
| 08/29/2002 | US20020119501 Diagnosis and treatment of PTP04 related disorders |
| 08/29/2002 | US20020119495 Immunogenic composition of hepatitis C and methods of use thereof |
| 08/29/2002 | US20020119494 Detection of modulators for the treatment chronic obstructive pulmonary disease; obtain sample containing membrane protein, incubate with modulator, monitor membrane protein activity |
| 08/29/2002 | US20020119493 Nucleotide sequences coding polypeptides for use in treatment and prevention of cell proliferative defects |
| 08/29/2002 | US20020119492 Modulating immunogenicity of a target protein; obtain protein sequence, record in computer, screen library for preferental amino acid sequences |
| 08/29/2002 | US20020119487 Human stem cell antigen 2 |
| 08/29/2002 | US20020119473 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer |
| 08/29/2002 | US20020119467 Amplifying enzymatic activity of polymerase; generate nucleotide sequence reaction mixture, incubate with polymerase and ribonucleic acid binding protein, monitor adjustment in polymerase biosynthetic activity |
| 08/29/2002 | US20020119464 Compositions and methods enabling a totally internally controlled amplification reaction |
| 08/29/2002 | US20020119460 Prostate cancer gene |
| 08/29/2002 | US20020119457 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide |
| 08/29/2002 | US20020119452 Nucleotide sequences coding protein for use in the diagnosis and treatment of osteoarthritis |
| 08/29/2002 | US20020119447 Non-a,non-b,non-c,non-c,non-d,non-e hepatitis reagents and methods for their use |
| 08/29/2002 | US20020119446 Screening viricides for use in the treatment of respiratory syncytial viral infections; obtain sample of virus, incubate with viricides, generate transcripts, compare transcrips to those generated in the absence of viricide |
| 08/29/2002 | US20020119445 Genetic engineering; prophylactic therapy |
| 08/29/2002 | US20020119440 Peripheral nerve type sodium channels |
| 08/29/2002 | US20020119202 For therapy of cancer and other angiogenic-dependent diseases |
| 08/29/2002 | US20020119167 Human adamts-1 protein, gene coding the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein |
| 08/29/2002 | US20020119165 Peptides for inhibition of herpes simplex virus entry |
| 08/29/2002 | US20020119163 Methods and compositions for protection against bovine viral deseases |
| 08/29/2002 | US20020119161 Contacting Bordetella pertussis culture into with calcium phosphate gel for separating pertussis filamentous hemagglutinin (FHA), pertactin (PRN, 69K-OMP), pertussis fimbriae (FIM), and pertussis toxin |